Activated Fes Protein Tyrosine Kinase Induces Terminal Macrophage Differentiation of Myeloid Progenitors (U937 Cells) and Activation of the Transcription Factor PU.1

REFERENCES

• Areces, L. B., P. Dello Sbarba, M. Jücker, E. Richard Stanley, and R. A. Feldman. 1994. Functional specificity of cytoplasmic and transmembrane tyrosine kinases: identification of 130- and 75-kilodalton substrates of c-fps/fes tyrosine kinase in macrophages. Mol. Cell. Biol. 14: 4606–4615.
   PubMedGoogle Scholar
• Aspenstrom, P. 1997. A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr. Biol. 7: 479–487.
   PubMed Web of Science ®Google Scholar
• Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka, J. S. Gutkind, A. S. Asch, E. Cesarman, M. C. Gershengorn, E. A. Mesri, and M. C. Gerhengorn. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86–89.
   PubMed Web of Science ®Google Scholar
• Behre, G., L. T. Smith, and D. G. Tenen. 1999. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. BioTechniques 26: 24-26, 28.
   PubMedGoogle Scholar
• Bibbins, K. B., H. Boeuf, and H. E. Varmus. 1993. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol. Cell. Biol. 13: 7278–7287.
   PubMedGoogle Scholar
• Bjorge, J. D., C. Bellagamba, H. C. Cheng, A. Tanaka, J. H. Wang, and D. J. Fujita. 1995. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms. J. Biol. Chem. 270: 24222–24228.
   PubMed Web of Science ®Google Scholar
• Breitman, T. R., S. E. Selonick, and S. J. Collins. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77: 2936–2940.
   PubMed Web of Science ®Google Scholar
• Brizzi, M. F., M. G. Aronica, A. Rosso, G. P. Bagnara, Y. Yarden, and L. Pegoraro. 1996. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J. Biol. Chem. 271: 3562–3567.
   PubMed Web of Science ®Google Scholar
• Carey, J. O., K. J. Posekany, J. E. deVente, G. R. Pettit, and D. K. Ways. 1996. Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition. Blood 87: 4316–4324.
   PubMedGoogle Scholar
• Carmier, J. F., and J. Samarut. 1986. Chicken myeloid stem cells infected by retroviruses carrying the v-fps oncogene do not require exogenous growth factors to differentiate in vitro. Cell 44: 159–165.
   PubMedGoogle Scholar
• Clarke, S., and S. Gordon. 1998. Myeloid-specific gene expression. J. Leukoc. Biol. 63: 153–168.
   PubMed Web of Science ®Google Scholar
• Cleveland, J. L., M. Dean, N. Rosenberg, J. Y. Wang, and U. R. Rapp. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9: 5685–5695.
   PubMed Web of Science ®Google Scholar
• Corey, S., A. Eguinoa, K. Puyana-Theall, J. B. Bolen, L. Cantley, F. Mollinedo, T. R. Jackson, P. T. Hawkins, and L. R. Stephens. 1993. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J. 12: 2681–2690.
   PubMed Web of Science ®Google Scholar
• Cortez, D., G. Reuther, and A. M. Pendergast. 1997. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Oncogene 15: 2333–2342.
   PubMed Web of Science ®Google Scholar
• Cunningham, M. A., P. Romas, P. Hutchinson, S. R. Holdsworth, and P. G. Tipping. 1999. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94: 3413–3420.
   PubMed Web of Science ®Google Scholar
• Fan, S. T., N. Mackman, M. Z. Cui, and T. S. Edgington. 1995. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J. Immunol. 154: 3266–3274.
   PubMed Web of Science ®Google Scholar
• Feldman, R. A., J. L. Gabrilove, J. P. Tam, M. A. Moore, and H. Hanafusa. 1985. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 82: 2379–2383.
   PubMed Web of Science ®Google Scholar
• Feldman, R. A., D. R. Lowy, and W. C. Vass. 1990. Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor. Oncogene Res. 5: 187–197.
   PubMedGoogle Scholar
• Feldman, R. A., W. C. Vass, and P. E. Tambourin. 1987. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential. Oncogene Res. 1: 441–458.
   PubMedGoogle Scholar
• Foster, D. A., and H. Hanafusa. 1983. A fps gene without gag gene sequences transforms cells in culture and induces tumors in chickens. J. Virol. 48: 744–751.
   PubMedGoogle Scholar
• Foster, D. A., M. Shibuya, and H. Hanafusa. 1985. Activation of the transformation potential of the cellular fps gene. Cell 42: 105–115.
   PubMedGoogle Scholar
• Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–467.
   PubMed Web of Science ®Google Scholar
• Greer, P., J. Haigh, G. Mbamalu, W. Khoo, A. Bernstein, and T. Pawson. 1994. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol. Cell. Biol. 14: 6755–6763.
   PubMed Web of Science ®Google Scholar
• Greer, P., V. Maltby, J. Rossant, A. Bernstein, and T. Pawson. 1990. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. Mol. Cell. Biol. 10: 2521–2527.
   PubMedGoogle Scholar
• Hackenmiller, R., J. Kim, R. A. Feldman, and M. C. Simon. 2000. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes−/− mice. Immunity 13: 397–407.
   PubMedGoogle Scholar
• Haigh, J., J. McVeigh, and P. Greer. 1996. The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network. Cell Growth Differ. 7: 931–944.
   PubMedGoogle Scholar
• Hampe, A., I. Laprevotte, F. Galibert, L. A. Fedele, and C. J. Sherr. 1982. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell 30: 775–785.
   PubMed Web of Science ®Google Scholar
• Hanafusa, H. 1988. The fps/fes oncogene, p. 39–57. In E. P. Reddy, A. M. Skalka, and T. Curran (ed.), The oncogene handbook. Elsevier Science Publishers B. V., Amsterdam, The Netherlands.
   Google Scholar
• Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, A. Miyajima, K. Arai, Y. Yazaki, and H. Hirai. 1993. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12: 1641–1646.
   PubMed Web of Science ®Google Scholar
• Harrison, D. A., R. Binari, T. S. Nahreini, M. Gilman, and N. Perrimon. 1995. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14: 2857–2865.
   PubMedGoogle Scholar
• Henkel, G. W., S. R. McKercher, H. Yamamoto, K. L. Anderson, R. G. Oshima, and R. A. Maki. 1996. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. Blood 88: 2917–2926.
   PubMedGoogle Scholar
• Heydemann, A., J. H. Boehmler, and M. C. Simon. 1997. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor. J. Biol. Chem. 272: 29527–29537.
   PubMedGoogle Scholar
• Heydemann, A., G. Juang, K. Hennessy, M. S. Parmacek, and M. C. Simon. 1996. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol. Cell. Biol. 16: 1676–1686.
   PubMedGoogle Scholar
• Heydemann, A., S. Warming, C. Clendenin, K. Sigrist, J. P. Hjorth, and M. C. Simon. 2000. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice. Blood 96: 3040–3048.
   PubMed Web of Science ®Google Scholar
• Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51–59.
   PubMed Web of Science ®Google Scholar
• Huang, C. C., C. Hammond, and J. M. Bishop. 1985. Nucleotide sequence and topography of chicken c-fps. Genesis of a retroviral oncogene encoding a tyrosine-specific protein kinase. J. Mol. Biol. 181: 175–186.
   PubMedGoogle Scholar
• Johnston, R. B. 1988. Current concepts: immunology. Monocytes and macrophages. N. Engl. J. Med. 318: 747–752.
   PubMed Web of Science ®Google Scholar
• Jücker, M., and R. A. Feldman. 1995. Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase. J. Biol. Chem. 270: 27817–27822.
   PubMed Web of Science ®Google Scholar
• Jücker, M., K. McKenna, A. J. da Silva, C. E. Rudd, and R. A. Feldman. 1997. The Fes protein-tyrosine kinase phosphorylates a subset of macrophage proteins that are involved in cell adhesion and cell-cell signaling. J. Biol. Chem. 272: 2104–2109.
   PubMedGoogle Scholar
• Kemler, I., E. Bucher, K. Seipel, M. M. Muller-Immergluck, and W. Schaffner. 1991. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration. Nucleic Acids Res. 19: 237–242.
   PubMedGoogle Scholar
• Kruger, A., and S. M. Anderson. 1991. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype. Oncogene 6: 245–256.
   PubMed Web of Science ®Google Scholar
• Lacronique, V., A. Boureux, V. D. Valle, H. Poirel, C. T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O. A. Bernard. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278: 1309–1312.
   PubMed Web of Science ®Google Scholar
• Laouar, A., F. R. Collart, C. B. Chubb, B. Xie, and E. Huberman. 1999. Interaction between alpha 5 beta 1 integrin and secreted fibronectin is involved in macrophage differentiation of human HL-60 myeloid leukemia cells. J. Immunol. 162: 407–414.
   PubMedGoogle Scholar
• Liebermann, D. A., and B. Hoffman-Liebermann. 1989. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene 4: 583–592.
   PubMedGoogle Scholar
• Lionberger, J. M., and T. E. Smithgall. 2000. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res. 60: 1097–1103.
   PubMed Web of Science ®Google Scholar
• Lodie, T. A., R. Savedra, D. T. Golenbock, C. P. Van Beveren, R. A. Maki, and M. J. Fenton. 1997. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158: 1848–1856.
   PubMedGoogle Scholar
• MacDonald, I., J. Levy, and T. Pawson. 1985. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell. Biol. 5: 2543–2551.
   PubMedGoogle Scholar
• Mach, F., U. Schonbeck, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396–399.
   PubMed Web of Science ®Google Scholar
• Mackman, N., K. Brand, and T. S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J. Exp. Med. 174: 1517–1526.
   PubMed Web of Science ®Google Scholar
• Manfredini, R., R. Balestri, E. Tagliafico, F. Trevisan, M. Pizzanelli, A. Grande, D. Barbieri, P. Zucchini, G. Citro, C. Franceschi, and S. Ferrari. 1997. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells. Blood 89: 135–145.
   PubMedGoogle Scholar
• Manfredini, R., A. Grande, E. Tagliafico, D. Barbieri, P. Zucchini, G. Citro, G. Zupi, C. Franceschi, U. Torelli, and S. Ferrari. 1993. Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J. Exp. Med. 178: 381–389.
   PubMed Web of Science ®Google Scholar
• Maru, Y., K. L. Peters, D. E. Afar, M. Shibuya, O. N. Witte, and T. E. Smithgall. 1995. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15: 835–842.
   PubMedGoogle Scholar
• Mathey-Prevot, B., H. Hanafusa, and S. Kawai. 1982. A cellular protein is immunologically crossreactive with and functionally homologous to the Fujinami sarcoma virus transforming protein. Cell 28: 897–906.
   PubMed Web of Science ®Google Scholar
• McKercher, S. R., B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and R. A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647–5658.
   PubMed Web of Science ®Google Scholar
• Metcalf, D. 1991. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254: 529–533.
   PubMed Web of Science ®Google Scholar
• Metcalf, D. 1989. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339: 27–30.
   PubMed Web of Science ®Google Scholar
• Nagulapalli, S., J. M. Pongubala, and M. L. Atchison. 1995. Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3). J. Immunol. 155: 4330–4338.
   PubMedGoogle Scholar
• Ojaniemi, M., S. S. Martin, F. Dolfi, J. M. Olefsky, and K. Vuori. 1997. The proto-oncogene product p120(cbl) links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway. J. Biol. Chem. 272: 3780–3787.
   PubMedGoogle Scholar
• Olson, M. C., E. W. Scott, A. A. Hack, G. H. Su, D. G. Tenen, H. Singh, and M. C. Simon. 1995. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3: 703–714.
   PubMedGoogle Scholar
• Pahl, H. L., R. J. Scheibe, D. E. Zhang, H. M. Chen, D. L. Galson, R. A. Maki, and D. G. Tenen. 1993. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 268: 5014–5020.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., J. P. Miller, L. Xu, J. C. Pui, B. Soffer, R. C. Quackenbush, A. M. Pendergast, R. Bronson, J. C. Aster, M. L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210bcr/abl-transduced bone marrow. Blood 92: 3780–3792.
   PubMed Web of Science ®Google Scholar
• Perkel, J. M., and M. L. Atchison. 1998. A two-step mechanism for recruitment of Pip by PU.1. J. Immunol. 160: 241–252.
   PubMedGoogle Scholar
• Pongubala, J. M., C. Van Beveren, S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1993. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259: 1622–1625.
   PubMedGoogle Scholar
• Quelle, F. W., N. Sato, B. A. Witthuhn, R. C. Inhorn, M. Eder, A. Miyajima, J. D. Griffin, and J. N. Ihle. 1994. JAK2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14: 4335–4341.
   PubMed Web of Science ®Google Scholar
• Radomska, H. S., C. S. Huettner, P. Zhang, T. Cheng, D. T. Scadden, and D. G. Tenen. 1998. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18: 4301–4314.
   PubMed Web of Science ®Google Scholar
• Roebroek, A. J., J. A. Schalken, C. Onnekink, H. P. Bloemers, and W. J. Van de Ven. 1987. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene. J. Virol. 61: 2009–2016.
   PubMedGoogle Scholar
• Roebroek, A. J., J. A. Schalken, J. S. Verbeek, A. M. Van den Ouweland, C. Onnekink, H. P. Bloemers, and W. J. Van de Ven. 1985. The structure of the human c-fes/fps proto-oncogene. EMBO J. 4: 2897–2903.
   PubMed Web of Science ®Google Scholar
• Rogers, J. A., R. D. Read, J. Li, K. L. Peters, and T. E. Smithgall. 1996. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. J. Biol. Chem. 271: 17519–17525.
   PubMedGoogle Scholar
• Samarut, J., B. Mathey-Prevot, and H. Hanafusa. 1985. Preferential expression of the c-fps protein in chicken macrophages and granulocytic cells. Mol. Cell. Biol. 5: 1067–1072.
   PubMedGoogle Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.
   PubMed Web of Science ®Google Scholar
• Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ′mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
   PubMed Web of Science ®Google Scholar
• Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573–1577.
   PubMed Web of Science ®Google Scholar
• Senis, Y., R. Zirngibl, J. McVeigh, A. Haman, T. Hoang, and P. A. Greer. 1999. Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. Mol. Cell. Biol. 19: 7436–7446.
   PubMedGoogle Scholar
• Shibuya, M., and H. Hanafusa. 1982. Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell 30: 787–795.
   PubMed Web of Science ®Google Scholar
• Shimozaki, K., K. Nakajima, T. Hirano, and S. Nagata. 1997. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272: 25184–25189.
   PubMed Web of Science ®Google Scholar
• Stein, P. H., J. D. Fraser, and A. Weiss. 1994. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14: 3392–3402.
   PubMedGoogle Scholar
• Taubman, M. B., J. T. Fallon, A. D. Schecter, P. Giesen, M. Mendlowitz, B. S. Fyfe, J. D. Marmur, and Y. Nemerson. 1997. Tissue factor in the pathogenesis of atherosclerosis. Thromb. Haemostasis 78: 200–204.
   PubMed Web of Science ®Google Scholar
• Thomas, S. M., P. Soriano, and A. Imamoto. 1995. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature 376: 267–271.
   PubMed Web of Science ®Google Scholar
• Torigoe, T., R. O'Connor, D. Santoli, and J. C. Reed. 1992. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood 80: 617–624.
   PubMed Web of Science ®Google Scholar
• Valledor, A. F., F. E. Borras, M. Cullell-Young, and A. Celada. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Biol. 63: 405–417.
   PubMed Web of Science ®Google Scholar
• Vuori, K., H. Hirai, S. Aizawa, and E. Ruoslahti. 1996. Introduction of p130 cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell. Biol. 16: 2606–2613.
   PubMed Web of Science ®Google Scholar
• Whalen, A. M., S. C. Galasinski, P. S. Shapiro, T. S. Nahreini, and N. G. Ahn. 1997. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17: 1947–1958.
   PubMed Web of Science ®Google Scholar
• Woodring, P. J., T. Hunter, and J. Y. Wang. 2001. Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J. Biol. Chem. 276: 27104–27110.
   PubMedGoogle Scholar
• Yam, L. T., C. Y. Li, and W. H. Crosby. 1971. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55: 283–290.
   PubMed Web of Science ®Google Scholar
• Yu, G., T. E. Smithgall, and R. I. Glazer. 1989. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J. Biol. Chem. 264: 10276–10281.
   PubMedGoogle Scholar